Enrique Soto Perez de Celis, Associate Professor at the University of Colorado Anschutz, shared a post on LinkedIn:
“Older adults account for the majority of people living with cancer, yet they remain underrepresented in clinical trials. Real-world data (RWD) and real-world evidence (RWE) offer an important opportunity to bridge this evidence gap and support more personalized, patient-centered care.
I’m pleased to share our new review․ In this paper, we discuss:
- How RWD can complement randomized clinical trials in older adults
- Opportunities to better understand treatment effectiveness, toxicity, quality of life, and healthcare utilization
- The role of electronic health records, registries, wearable devices, and patient-reported outcomes
- Current challenges, including data quality, confounding, standardization, and ethical considerations
- Future directions, including artificial intelligence, decentralized clinical trials, and global data networks
Many thanks to my co-authors Adolfo González-Serrano, Charline Jean, Capucine Baldini for a fantastic collaboration.”
Title: Leveraging Real‑World Data for Clinical Decision Making in Geriatric Oncology
Read the Full Article.
Other articles about Geriatric Oncology on OncoDaily.